Literature DB >> 10438201

AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors.

H J Bühring, M Seiffert, A Marxer, B Weiss, C Faul, L Kanz, W Brugger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438201

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  CD34+ and CD133+ Primitive Stem Cell Expression in Peripheral Blood: Considering Gender, Age, and Smoking.

Authors:  Heike Reichelt; Dagmar Barz; Hansjörg Thude
Journal:  Transfus Med Hemother       Date:  2009-03-06       Impact factor: 3.747

2.  Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease.

Authors:  Chi-Chao Chan; Emily Y Chew; Defen Shen; Joseph Hackett; Zhengping Zhuang
Journal:  Mol Vis       Date:  2005-09-01       Impact factor: 2.367

3.  Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes.

Authors:  G Perrella; P Brusini; R Spelat; P Hossain; A Hopkinson; H S Dua
Journal:  Br J Ophthalmol       Date:  2006-09-06       Impact factor: 4.638

4.  Expression of CD133 in acute leukemia.

Authors:  Fetnat M Tolba; Mona E Foda; Howyda M Kamal; Deena A Elshabrawy
Journal:  Med Oncol       Date:  2013-03-27       Impact factor: 3.064

Review 5.  Cancer stem cells in brain tumor biology.

Authors:  J N Rich; C E Eyler
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2009-03-27

6.  CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers.

Authors:  L M Smith; A Nesterova; M C Ryan; S Duniho; M Jonas; M Anderson; R F Zabinski; M K Sutherland; H-P Gerber; K L Van Orden; P A Moore; S M Ruben; P J Carter
Journal:  Br J Cancer       Date:  2008-06-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.